Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Madagascar Health Press.
Press releases published on June 25, 2025
Dr. Anosh Ahmed Expands National and International COVID Testing Operations with Renewed Emphasis on Compliance and Fraud Prevention
GlobeNewswire
·
June 25, 2025
Chicago, Illinois, June 25, 2025 (GLOBE NEWSWIRE) -- Dr. Anosh Ahmed announces the expansion of his COVID-19 testing operations across the United States and internationally, building on his proven record of delivering high-quality testing services with a …
Lifeward Announces Pricing of $2.6 Million Public Offering
GlobeNewswire
·
June 25, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or …
Aprea Reports Anti-Proliferative Results and Promising Early-Stage Clinical Data for Next-Generation WEE1 Inhibitor, APR-1051, in HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Collaboration with MD Anderson Cancer Center
GlobeNewswire
·
June 25, 2025
Preclinical data demonstrate potent single-agent and combination effects in head and neck squamous cell carcinoma (HNSCC) models, including synergy with anti–PD-1 therapy Initial Phase 1 clinical update shows early disease control in first HPV+ patient …
Commure Launches Commure Agents – AI Assistants That Fully Automate Physician Workflows
GlobeNewswire
·
June 25, 2025
MOUNTAIN VIEW, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Commure, a leading healthcare technology company, today announced the commercial launch of Commure Agents, AI-powered colleagues built for healthcare. Commure Agents are intelligent, customizable …
Serenity Recovery Network Named Finalist for $100,000 Impact 100 Grant
GlobeNewswire
·
June 25, 2025
CINCINNATI, June 25, 2025 (GLOBE NEWSWIRE) -- Serenity Recovery Network (SRN) is honored to announce its selection as a finalist for a $100,000 grant from Impact 100. This prestigious recognition highlights SRN’s innovative approach to expanding recovery …
Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control
GlobeNewswire
·
June 25, 2025
ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic …
Akari Therapeutics Releases Virtual Investor “What This Means” Segment Highlighting its Recently Granted India Patent
GlobeNewswire
·
June 25, 2025
Access the “What This Means” segment here BOSTON and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the …
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
GlobeNewswire
·
June 25, 2025
SARASOTA, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility sector, today announced it has received a notice of allowance on a new patent for a …
Celebrating National Sunglasses Day: The Science Behind the Style
GlobeNewswire
·
June 25, 2025
Alexandria, Virginia, June 25, 2025 (GLOBE NEWSWIRE) -- Sunglasses may be a hallmark of personal style, but eyecare professionals and health experts agree: their most important role is protection. In anticipation of National Sunglasses Day celebrations on …
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
GlobeNewswire
·
June 25, 2025
Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel …
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
June 25, 2025
June 25, 2025 Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company …
Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply
GlobeNewswire
·
June 25, 2025
Scope of Agreement with Cambrex to Provide Ondansetron HCL Drug Substance Under FDA Approved Drug Master File Scope Of Agreement With Thermo Fisher to Provide Manufacturing Services Including Demonstration, Clinical, Registration And Validation Batches of …
Hepion Pharmaceuticals Successfully Completes Application to the OTCQB
GlobeNewswire
·
June 25, 2025
MORRISTOWN, N.J., June 25, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (OTCQB:HEPA), a clinical stage biopharmaceutical company that is developing and commercializing diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B …
Intelligent Bio Solutions and Spjotgard Drive Rapid Adoption of Fingerprint Drug Testing Across Scandinavia
GlobeNewswire
·
June 25, 2025
NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening solutions, today announced the success of its ongoing …
Eyenovia Announces Co-Branded Validator with Kinetiq
GlobeNewswire
·
June 25, 2025
LAGUNA HILLS, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of …
Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
GlobeNewswire
·
June 25, 2025
RUTHERFORD, N.J. and STOCKHOLM, June 25, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced results …
Ernexa Therapeutics Expands Advisory Board to Form Integrated Scientific and Medical Advisory Board as it Prepares for Clinical Development
GlobeNewswire
·
June 25, 2025
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced the expansion of its Scientific Advisory Board to a …
Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech
GlobeNewswire
·
June 25, 2025
Yokneam Illit, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, …
OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting Strategic Progress
GlobeNewswire
·
June 25, 2025
MINNEAPOLIS, June 25, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced today that Aaron Green, President and CEO, issued the following letter to …
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
GlobeNewswire
·
June 25, 2025
BERKELEY, Calif. and MAINZ, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that its …